{
    "hands_on_practices": [
        {
            "introduction": "In clinical enzymology, the journey from a sample in a machine to a reportable result begins with spectrophotometry. This exercise models the core calculation that converts a measured rate of absorbance change, $\\Delta A/\\text{min}$, into enzyme activity. By applying the Beer-Lambert law to a kinetic assay, you will practice converting raw instrument data into the standard clinical units of U/L, a foundational skill for any laboratory professional. ",
            "id": "5234582",
            "problem": "A continuous-monitoring enzymatic assay is performed at a wavelength of $340\\,\\text{nm}$, where only the reduced form of nicotinamide adenine dinucleotide (NADH) absorbs. The reaction has a $1{:}1$ stoichiometry between product formation and NADH formation. The cuvette has an optical path length of $l=1.00\\,\\text{cm}$. The chromophore’s molar absorptivity at $340\\,\\text{nm}$ is $\\varepsilon=6.22\\times 10^{3}\\,\\text{L mol}^{-1}\\text{cm}^{-1}$. Upon addition of a patient serum sample, the absorbance increases linearly at a rate of $\\Delta A/\\text{min}=0.120$. The total reaction volume in the cuvette is $1.00\\,\\text{mL}$ and contains a measured aliquot of the patient serum of $50.0\\,\\mu\\text{L}$, with the remainder being assay reagents. The International Unit (U) is defined as $1\\,\\mu\\text{mol}\\,\\text{min}^{-1}$ of product formed under the specified assay conditions. Using only first principles appropriate to clinical enzymology, compute the enzyme activity of the original patient serum in $\\text{U}/\\text{L}$. Round your final result to three significant figures and express it in $\\text{U}/\\text{L}$.",
            "solution": "The problem requires the calculation of enzyme activity in a patient serum sample, expressed in International Units per Liter ($\\text{U}/\\text{L}$), based on a continuous-monitoring enzymatic assay. The validation of the problem statement is the first step.\n\n### Step 1: Extract Givens\n- Wavelength of measurement: $340\\,\\text{nm}$\n- Absorbing species: Reduced form of nicotinamide adenine dinucleotide (NADH) only\n- Stoichiometry: $1{:}1$ between product formation and NADH formation\n- Optical path length: $l=1.00\\,\\text{cm}$\n- Molar absorptivity of NADH at $340\\,\\text{nm}$: $\\varepsilon=6.22\\times 10^{3}\\,\\text{L mol}^{-1}\\text{cm}^{-1}$\n- Rate of absorbance increase: $\\frac{\\Delta A}{\\Delta t}=0.120\\,\\text{min}^{-1}$\n- Total reaction volume in cuvette: $V_{\\text{total}}=1.00\\,\\text{mL}$\n- Volume of patient serum aliquot: $V_{\\text{serum}}=50.0\\,\\mu\\text{L}$\n- Definition of International Unit: $1\\,\\text{U} = 1\\,\\mu\\text{mol}\\,\\text{min}^{-1}$ of product formed\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded, relying on the Beer-Lambert law and standard definitions in clinical enzymology. All provided values, such as the molar absorptivity of NADH at $340\\,\\text{nm}$, are standard and factually correct. The problem is well-posed, objective, and self-contained, providing all necessary data for a unique solution. The units are consistent, and the setup is physically realistic for a laboratory setting. No flaws according to the specified criteria are detected.\n\n### Step 3: Verdict and Action\nThe problem is valid. A complete, reasoned solution will be provided.\n\n### Solution Derivation\nThe fundamental principle governing the relationship between absorbance and concentration is the Beer-Lambert law:\n$$ A = \\varepsilon c l $$\nwhere $A$ is the absorbance (dimensionless), $\\varepsilon$ is the molar absorptivity ($\\text{L mol}^{-1}\\text{cm}^{-1}$), $c$ is the concentration of the absorbing species ($\\text{mol L}^{-1}$), and $l$ is the optical path length ($\\text{cm}$).\n\nIn a continuous-monitoring assay, we measure the rate of change of absorbance over time, $\\frac{dA}{dt}$. Since $\\varepsilon$ and $l$ are constants for a given experimental setup, we can differentiate the Beer-Lambert law with respect to time ($t$) to relate the rate of absorbance change to the rate of concentration change of the absorbing species (NADH):\n$$ \\frac{dA}{dt} = \\varepsilon l \\frac{dc_{\\text{NADH}}}{dt} $$\nThe problem provides the rate of absorbance change as $\\frac{\\Delta A}{\\Delta t} = 0.120\\,\\text{min}^{-1}$. We can solve for the rate of change of NADH concentration in the cuvette:\n$$ \\frac{dc_{\\text{NADH}}}{dt} = \\frac{1}{\\varepsilon l} \\frac{dA}{dt} $$\nThis expression gives the rate of change of concentration in units of $\\text{mol L}^{-1}\\text{min}^{-1}$. To find the enzyme activity, which is defined in terms of the amount of substance (moles) of product formed per unit time, we must multiply the rate of concentration change by the total volume of the reaction mixture in the cuvette, $V_{\\text{total}}$.\nLet $n_{\\text{NADH}}$ be the amount of NADH in moles. The rate of formation of NADH in the cuvette is:\n$$ \\frac{dn_{\\text{NADH}}}{dt} = V_{\\text{total}} \\frac{dc_{\\text{NADH}}}{dt} = \\frac{V_{\\text{total}}}{\\varepsilon l} \\frac{dA}{dt} $$\nThe problem states a $1{:}1$ stoichiometry between product formation and NADH formation, meaning the rate of formation of product, $\\frac{dn_{\\text{product}}}{dt}$, is equal to the rate of formation of NADH:\n$$ \\frac{dn_{\\text{product}}}{dt} = \\frac{dn_{\\text{NADH}}}{dt} = \\frac{V_{\\text{total}}}{\\varepsilon l} \\frac{dA}{dt} $$\nThis quantity represents the total enzyme activity within the cuvette, in units of $\\text{mol min}^{-1}$. The International Unit (U) is defined as $1\\,\\mu\\text{mol min}^{-1}$. To express the activity in the cuvette, $\\text{Activity}_{\\text{cuvette}}$, in units of U, we must convert from moles to micromoles:\n$$ \\text{Activity}_{\\text{cuvette}} [\\text{U}] = \\frac{dn_{\\text{product}}}{dt} \\left[\\frac{\\text{mol}}{\\text{min}}\\right] \\times \\frac{10^6\\,\\mu\\text{mol}}{1\\,\\text{mol}} = \\frac{V_{\\text{total}}}{\\varepsilon l} \\frac{dA}{dt} \\times 10^6 $$\nThis activity originates from the enzyme contained in the aliquot of patient serum, $V_{\\text{serum}}$. To find the enzyme activity concentration in the original patient serum, we must divide the activity in the cuvette by the volume of the serum sample that was added. It is critical that all volumes are expressed in consistent units. We will convert all volumes to Liters (L).\n\nGiven values:\n- $\\frac{dA}{dt} = 0.120\\,\\text{min}^{-1}$\n- $\\varepsilon = 6.22 \\times 10^{3}\\,\\text{L mol}^{-1}\\text{cm}^{-1}$\n- $l = 1.00\\,\\text{cm}$\n- $V_{\\text{total}} = 1.00\\,\\text{mL} = 1.00 \\times 10^{-3}\\,\\text{L}$\n- $V_{\\text{serum}} = 50.0\\,\\mu\\text{L} = 50.0 \\times 10^{-6}\\,\\text{L}$\n\nThe final expression for the enzyme activity concentration in the serum, $\\text{Activity}_{\\text{serum}}$, in $\\text{U}/\\text{L}$ is:\n$$ \\text{Activity}_{\\text{serum}} \\left[\\frac{\\text{U}}{\\text{L}}\\right] = \\frac{\\text{Activity}_{\\text{cuvette}}[\\text{U}]}{V_{\\text{serum}}[\\text{L}]} = \\frac{1}{V_{\\text{serum}}} \\left( \\frac{V_{\\text{total}}}{\\varepsilon l} \\frac{dA}{dt} \\times 10^6 \\right) $$\nSubstituting the numerical values into the expression:\n$$ \\text{Activity}_{\\text{serum}} = \\frac{1.00 \\times 10^{-3}\\,\\text{L}}{(50.0 \\times 10^{-6}\\,\\text{L}) \\times (6.22 \\times 10^{3}\\,\\text{L mol}^{-1}\\text{cm}^{-1}) \\times (1.00\\,\\text{cm})} \\times (0.120\\,\\text{min}^{-1}) \\times 10^6 \\frac{\\mu\\text{mol}}{\\text{mol}} $$\nThe units resolve as follows:\n$$ \\frac{\\text{L}}{\\text{L} \\cdot (\\text{L mol}^{-1}\\text{cm}^{-1}) \\cdot \\text{cm}} \\cdot \\text{min}^{-1} \\cdot \\frac{\\mu\\text{mol}}{\\text{mol}} = \\frac{\\text{mol}}{\\text{L} \\cdot \\text{min}} \\cdot \\frac{\\mu\\text{mol}}{\\text{mol}} = \\frac{\\mu\\text{mol}}{\\text{L} \\cdot \\text{min}} $$\nSince $1\\,\\text{U} = 1\\,\\mu\\text{mol min}^{-1}$, the final units are $\\text{U}/\\text{L}$, as required.\n\nNow, we compute the numerical value:\n$$ \\text{Activity}_{\\text{serum}} = \\frac{(1.00 \\times 10^{-3}) \\times 0.120}{(50.0 \\times 10^{-6}) \\times (6.22 \\times 10^{3}) \\times 1.00} \\times 10^6 $$\n$$ \\text{Activity}_{\\text{serum}} = \\frac{1.20 \\times 10^{-4}}{50.0 \\times 6.22 \\times 10^{-3}} \\times 10^6 $$\n$$ \\text{Activity}_{\\text{serum}} = \\frac{1.20 \\times 10^{-4}}{311 \\times 10^{-3}} \\times 10^6 $$\n$$ \\text{Activity}_{\\text{serum}} = \\frac{1.20}{311} \\times 10^{-1} \\times 10^6 = \\frac{1.20}{311} \\times 10^5 $$\n$$ \\text{Activity}_{\\text{serum}} \\approx 0.00385852... \\times 10^5 = 385.852... \\,\\text{U}/\\text{L} $$\nThe problem requires the result to be rounded to three significant figures. The input data ($0.120$, $1.00$, $6.22$, $1.00$, $50.0$) all have three significant figures.\n$$ \\text{Activity}_{\\text{serum}} \\approx 386 \\,\\text{U}/\\text{L} $$",
            "answer": "$$\n\\boxed{386}\n$$"
        },
        {
            "introduction": "While total enzyme activity is useful, diagnosing specific conditions often requires measuring individual isoenzymes, such as Creatine Kinase-MB (CK-MB) for cardiac assessment. This practice delves into the clever technique of immunoinhibition, where antibodies are used to selectively silence parts of the enzyme machinery. You will learn to piece together multiple measurements to isolate the activity of a single isoenzyme, accounting for potential interferences and mastering a more advanced diagnostic calculation. ",
            "id": "5234598",
            "problem": "A clinical chemistry laboratory quantifies the activity of Creatine Kinase MB isoenzyme (CK-MB) using an immunoinhibition method in a coupled ultraviolet spectrophotometric assay that monitors the formation of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) at $340\\,\\mathrm{nm}$. In this method, antibodies against the Creatine Kinase M subunit (CK-M) fully inhibit the activity of the M subunit in both the CK-MM homodimer and the CK-MB heterodimer. As a result, the residual activity measured after immunoinhibition arises from CK-B subunits: the B subunit in CK-MB and any CK-BB or macro-CK forms that are not affected by the anti-M antibodies. Macro-CK (frequently immunoglobulin-bound CK-BB) is assessed by a Polyethylene Glycol (PEG) precipitation step. The laboratory wishes to determine the CK-MB activity while correctly accounting for macro-CK.\n\nAssay conditions and measurements are as follows:\n- Total reaction volume $V_{\\mathrm{tot}} = 1.20 \\times 10^{-3}\\,\\mathrm{L}$.\n- Serum sample volume $V_{s} = 5.00 \\times 10^{-5}\\,\\mathrm{L}$.\n- Optical pathlength $l = 1.00\\,\\mathrm{cm}$.\n- Molar absorptivity of NADPH at $340\\,\\mathrm{nm}$ is $\\varepsilon = 6.22 \\times 10^{3}\\,\\mathrm{L}\\,\\mathrm{mol}^{-1}\\,\\mathrm{cm}^{-1}$.\n- Measured rate of increase in absorbance at $340\\,\\mathrm{nm}$ without immunoinhibition (total CK assay): $\\Delta A_{\\mathrm{total}}/\\mathrm{min} = 0.140$.\n- Measured residual rate of increase in absorbance after anti-M immunoinhibition, before PEG treatment: $\\Delta A_{\\mathrm{res,\\,prePEG}}/\\mathrm{min} = 0.020$.\n- Measured residual rate of increase in absorbance after anti-M immunoinhibition, following PEG precipitation (macro-CK removed from the supernatant): $\\Delta A_{\\mathrm{res,\\,postPEG}}/\\mathrm{min} = 0.014$.\n- Isoenzyme electrophoresis shows that CK-BB constitutes a fraction $f_{\\mathrm{BB}} = 0.005$ of the total CK activity.\n\nUse the Beer–Lambert law and the definition of one International Unit of enzyme activity ($1\\,\\mathrm{U} = 1\\,\\mu\\mathrm{mol}\\,\\mathrm{min}^{-1}$ under the stated conditions) to derive an expression that converts a measured $\\Delta A/\\mathrm{min}$ into enzyme activity in $\\mathrm{U}/\\mathrm{L}$, given the assay geometry above. Then, apply immunoinhibition principles to determine the correction needed to infer the full CK-MB activity from the residual B-subunit activity measured after anti-M immunoinhibition. Account quantitatively for macro-CK by using the PEG-treated measurement and for CK-BB by using the electrophoretic fraction $f_{\\mathrm{BB}}$ of the total activity. Finally, compute the CK-MB activity and express the result in $\\mathrm{U}/\\mathrm{L}$. Round your final numeric answer to four significant figures.",
            "solution": "The problem requires the calculation of Creatine Kinase MB isoenzyme (CK-MB) activity from a series of spectrophotometric measurements using an immunoinhibition assay. The solution involves applying the Beer-Lambert law, understanding the principles of enzyme kinetics and units, and correctly interpreting the effects of immunoinhibition and sample treatment steps on the different CK isoenzymes.\n\nFirst, we derive a general expression to convert the rate of change of absorbance ($\\Delta A/\\mathrm{min}$) into enzyme activity in International Units per liter ($\\mathrm{U}/\\mathrm{L}$). One International Unit ($1\\,\\mathrm{U}$) is defined as the amount of enzyme that catalyzes the conversion of $1\\,\\mu\\mathrm{mol}$ of substrate per minute. The activity in $\\mathrm{U}/\\mathrm{L}$ is therefore expressed in units of $\\mu\\mathrm{mol}\\,\\mathrm{min}^{-1}\\,\\mathrm{L}^{-1}$.\n\nThe Beer-Lambert law states $A = \\varepsilon c l$, where $A$ is absorbance, $\\varepsilon$ is the molar absorptivity, $c$ is the concentration of the absorbing species (NADPH in this case), and $l$ is the optical pathlength. The rate of formation of NADPH in the reaction cuvette is related to the rate of change of absorbance:\n$$\n\\frac{d A}{dt} = \\varepsilon l \\frac{d c}{dt}\n$$\nThe rate of reaction in the cuvette, $v_{\\mathrm{cuvette}} = dc/dt$, in units of $\\mathrm{mol}\\,\\mathrm{L}^{-1}\\,\\mathrm{min}^{-1}$, can be expressed as:\n$$\nv_{\\mathrm{cuvette}} = \\frac{1}{\\varepsilon l} \\frac{\\Delta A}{\\mathrm{min}}\n$$\nwhere $\\Delta A/\\mathrm{min}$ is the measured rate of absorbance increase.\n\nThe total catalytic rate in the cuvette is the reaction rate multiplied by the total reaction volume, $V_{\\mathrm{tot}}$. This catalytic activity originates from the serum sample of volume $V_{s}$. Therefore, the enzyme activity concentration in the original serum is:\n$$\n\\text{Activity}_{\\text{serum}} \\left(\\frac{\\mathrm{mol}}{\\mathrm{min} \\cdot \\mathrm{L}}\\right) = \\frac{v_{\\mathrm{cuvette}} \\cdot V_{\\mathrm{tot}}}{V_{s}} = \\left(\\frac{1}{\\varepsilon l} \\frac{\\Delta A}{\\mathrm{min}}\\right) \\frac{V_{\\mathrm{tot}}}{V_{s}}\n$$\nTo express this activity in $\\mathrm{U}/\\mathrm{L}$ ($\\mu\\mathrm{mol}\\,\\mathrm{min}^{-1}\\,\\mathrm{L}^{-1}$), we must multiply by $10^6\\,\\mu\\mathrm{mol}/\\mathrm{mol}$:\n$$\n\\text{Activity} \\left(\\frac{\\mathrm{U}}{\\mathrm{L}}\\right) = \\frac{10^6 \\cdot V_{\\mathrm{tot}}}{\\varepsilon \\cdot l \\cdot V_{s}} \\left(\\frac{\\Delta A}{\\mathrm{min}}\\right)\n$$\nThis is the required general expression. Let's define a conversion factor $K$:\n$$\nK = \\frac{10^6 \\cdot V_{\\mathrm{tot}}}{\\varepsilon \\cdot l \\cdot V_{s}}\n$$\nUsing the provided values: $V_{\\mathrm{tot}} = 1.20 \\times 10^{-3}\\,\\mathrm{L}$, $V_{s} = 5.00 \\times 10^{-5}\\,\\mathrm{L}$, $l = 1.00\\,\\mathrm{cm}$, and $\\varepsilon = 6.22 \\times 10^{3}\\,\\mathrm{L}\\,\\mathrm{mol}^{-1}\\,\\mathrm{cm}^{-1}$:\n$$\nK = \\frac{10^6 \\cdot (1.20 \\times 10^{-3})}{(6.22 \\times 10^{3}) \\cdot (1.00) \\cdot (5.00 \\times 10^{-5})} = \\frac{1.20 \\times 10^3}{3.11 \\times 10^{-1}} = \\frac{1200}{0.311} \\, \\frac{\\mathrm{U} \\cdot \\mathrm{min}}{\\mathrm{L}}\n$$\nNext, we analyze the components of CK activity. Total CK activity ($A_{\\mathrm{total}}$) is the sum of activities from all isoenzymes: CK-MM, CK-MB, CK-BB, and macro-CK.\n$$\nA_{\\mathrm{total}} = A_{\\mathrm{MM}} + A_{\\mathrm{MB}} + A_{\\mathrm{BB}} + A_{\\mathrm{Macro}}\n$$\nThe immunoinhibition assay uses antibodies to the M-subunit. This completely inhibits CK-MM (M-M dimer). For the CK-MB heterodimer (M-B), only the M-subunit is inhibited. Assuming the M and B subunits contribute equally to the enzymatic activity, the residual activity from a CK-MB molecule is half of its original activity. This means that to find the full $A_{\\mathrm{MB}}$, the measured residual activity from its B-subunit must be multiplied by a factor of $2$. CK-BB and macro-CK (typically immunoglobulin-bound CK-BB) lack M-subunits and are unaffected by the antibody.\n\nThe residual activity measured before PEG treatment ($A_{\\mathrm{res,prePEG}}$) is the sum of all uninhibited activities:\n$$\nA_{\\mathrm{res,prePEG}} = \\frac{1}{2} A_{\\mathrm{MB}} + A_{\\mathrm{BB}} + A_{\\mathrm{Macro}}\n$$\nThe PEG precipitation step removes large molecules, including macro-CK. The residual activity measured in the supernatant after PEG treatment ($A_{\\mathrm{res,postPEG}}$) is therefore:\n$$\nA_{\\mathrm{res,postPEG}} = \\frac{1}{2} A_{\\mathrm{MB}} + A_{\\mathrm{BB}}\n$$\nFrom these equations, we can isolate the activity of each component. First, the macro-CK activity is the difference between the pre- and post-PEG residual activities:\n$$\nA_{\\mathrm{Macro}} = A_{\\mathrm{res,prePEG}} - A_{\\mathrm{res,postPEG}}\n$$\nThe problem states that CK-BB constitutes a fraction $f_{\\mathrm{BB}} = 0.005$ of the total CK activity:\n$$\nA_{\\mathrm{BB}} = f_{\\mathrm{BB}} \\cdot A_{\\mathrm{total}}\n$$\nWe can now solve for the residual CK-MB activity ($\\frac{1}{2} A_{\\mathrm{MB}}$) using the post-PEG measurement:\n$$\n\\frac{1}{2} A_{\\mathrm{MB}} = A_{\\mathrm{res,postPEG}} - A_{\\mathrm{BB}} = A_{\\mathrm{res,postPEG}} - (f_{\\mathrm{BB}} \\cdot A_{\\mathrm{total}})\n$$\nThe full CK-MB activity is twice this value:\n$$\nA_{\\mathrm{MB}} = 2 \\left( A_{\\mathrm{res,postPEG}} - f_{\\mathrm{BB}} \\cdot A_{\\mathrm{total}} \\right)\n$$\nWe can now convert the given absorbance rates into activities in $\\mathrm{U}/\\mathrm{L}$ using the conversion factor $K$:\n$$\nA_{\\mathrm{total}} = K \\cdot \\left(\\frac{\\Delta A_{\\mathrm{total}}}{\\mathrm{min}}\\right) = K \\cdot 0.140\n$$\n$$\nA_{\\mathrm{res,postPEG}} = K \\cdot \\left(\\frac{\\Delta A_{\\mathrm{res,\\,postPEG}}}{\\mathrm{min}}\\right) = K \\cdot 0.014\n$$\nSubstituting these into the expression for $A_{\\mathrm{MB}}$:\n$$\nA_{\\mathrm{MB}} = 2 \\left( K \\cdot 0.014 - f_{\\mathrm{BB}} \\cdot (K \\cdot 0.140) \\right)\n$$\n$$\nA_{\\mathrm{MB}} = 2K \\left( 0.014 - f_{\\mathrm{BB}} \\cdot 0.140 \\right)\n$$\nPlugging in the value $f_{\\mathrm{BB}} = 0.005$:\n$$\nA_{\\mathrm{MB}} = 2K \\left( 0.014 - 0.005 \\cdot 0.140 \\right)\n$$\n$$\nA_{\\mathrm{MB}} = 2K \\left( 0.014 - 0.0007 \\right)\n$$\n$$\nA_{\\mathrm{MB}} = 2K \\left( 0.0133 \\right) = K \\cdot 0.0266\n$$\nFinally, we substitute the numerical value of $K$:\n$$\nA_{\\mathrm{MB}} = \\left(\\frac{1200}{0.311}\\right) \\cdot 0.0266\n$$\n$$\nA_{\\mathrm{MB}} \\approx (3858.5209) \\cdot 0.0266 \\approx 102.6366559... \\, \\mathrm{U}/\\mathrm{L}\n$$\nRounding the final answer to four significant figures, we get $102.6\\,\\mathrm{U}/\\mathrm{L}$.",
            "answer": "$$\n\\boxed{102.6}\n$$"
        },
        {
            "introduction": "A change in a patient's enzyme level over time can signal disease progression or response to treatment, but not all changes are clinically meaningful. This exercise introduces the crucial concept of the Reference Change Value (RCV), a statistical tool used to determine if the difference between two serial measurements is significant or likely due to analytical and biological noise. By mastering the calculation and application of the RCV, you will learn to interpret serial laboratory data with statistical confidence. ",
            "id": "5234547",
            "problem": "A clinical laboratory is monitoring serial results of Alanine Aminotransferase (ALT) for an individual patient. The assay has an analytical coefficient of variation (CV) of $CV_{a} = 3\\%$, and the within-subject biological variation is $CV_{w} = 8\\%$. Assume that analytical and biological sources of imprecision are independent, that each source contributes additively to variance, and that serial results for a stable individual are approximately normally distributed on the linear scale. Let $z = 1.96$ be the standard normal quantile associated with a two-sided $95\\%$ criterion.\n\nUsing only the definitions of coefficient of variation, independence of error sources, and the propagation of variance for the difference of two independent measurements, derive from first principles the expression for the Reference Change Value (RCV) as a fraction (dimensionless) for two serial results measured under the same conditions. Then evaluate this expression numerically using $CV_{a}$ and $CV_{w}$ as given. For two consecutive ALT results of $R_{1} = 120$ U/L and $R_{2} = 140$ U/L, define the dimensionless ratio\n$$r \\equiv \\frac{|R_{2} - R_{1}|}{RCV \\times R_{1}}.$$\nReport $r$ rounded to four significant figures. Your final answer must be this single number, which can be interpreted as follows: if $r \\geq 1$, the change meets the RCV criterion and is considered statistically significant at the two-sided $95\\%$ level; if $r < 1$, it does not.",
            "solution": "Begin with the definition of the coefficient of variation for a single measurement, which is the ratio of the standard deviation to the mean. Let $CV_{a}$ denote the analytical coefficient of variation and $CV_{w}$ denote the within-subject biological coefficient of variation. Under the assumption of independence of these two sources of imprecision, the relative variance (that is, variance normalized by the squared mean) of a single measurement is the sum of the component relative variances:\n$$CV_{\\text{total}}^{2} = CV_{a}^{2} + CV_{w}^{2}.$$\n\nFor two independent measurements on the same individual under the same conditions, $R_{1}$ and $R_{2}$, the variance of the difference $D = R_{2} - R_{1}$ is the sum of the variances of each measurement:\n$$\\operatorname{Var}(D) = \\operatorname{Var}(R_{2}) + \\operatorname{Var}(R_{1}).$$\nExpressed in relative terms with respect to the mean level (approximated locally by $R_{1}$ for assessing change around the first value), the relative standard deviation (RSD) of the difference is\n$$\\text{RSD}(D) = \\sqrt{2} \\times \\sqrt{CV_{a}^{2} + CV_{w}^{2}}.$$\n\nA change $|R_{2} - R_{1}|$ is considered statistically significant at a two-sided level associated with a standard normal quantile $z$ when it exceeds $z$ times the standard deviation of the difference. Expressed in fractional (dimensionless) form relative to $R_{1}$, the Reference Change Value (RCV) is therefore\n$$RCV = z \\times \\sqrt{2} \\times \\sqrt{CV_{a}^{2} + CV_{w}^{2}}.$$\n\nSubstitute the given values $CV_{a} = 3\\% = 0.03$, $CV_{w} = 8\\% = 0.08$, and $z = 1.96$:\n$$CV_{a}^{2} + CV_{w}^{2} = (0.03)^{2} + (0.08)^{2} = 0.0009 + 0.0064 = 0.0073,$$\n$$\\sqrt{CV_{a}^{2} + CV_{w}^{2}} = \\sqrt{0.0073} \\approx 0.08544003745317531,$$\n$$\\sqrt{2} \\times \\sqrt{CV_{a}^{2} + CV_{w}^{2}} \\approx 1.4142135623730951 \\times 0.08544003745317531 \\approx 0.120839287170,$$\n$$RCV = 1.96 \\times 0.120839287170 \\approx 0.236845002853.$$\n\nThus, the fractional RCV is approximately $0.236845002853$ (dimensionless). Next, compute the ratio\n$$r \\equiv \\frac{|R_{2} - R_{1}|}{RCV \\times R_{1}}.$$\nWith $R_{1} = 120$ and $R_{2} = 140$, we have\n$$|R_{2} - R_{1}| = |140 - 120| = 20,$$\n$$RCV \\times R_{1} \\approx 0.236845002853 \\times 120 \\approx 28.4214003423,$$\n$$r \\approx \\frac{20}{28.4214003423} \\approx 0.7037.$$\n\nThe ratio $r \\approx 0.7037$ is less than $1$, which implies that the observed increase from $120$ U/L to $140$ U/L does not meet the Reference Change Value criterion for statistical significance at the two-sided $95\\%$ level. Per the problem instructions, the required final answer is the single number $r$ rounded to four significant figures.",
            "answer": "$$\\boxed{0.7037}$$"
        }
    ]
}